Megan Boston
Equibles does not estimate personal net worth.
Get an email with a short summary when Benitec Biopharma Inc. publishes a filing, an earnings call transcript or a press release.
Get BNTC alertsAbout Megan Boston
Megan Boston is recorded as CFO at Benitec Biopharma Inc. (BNTC). The newest filing on record that lists Megan Boston as CFO at Benitec Biopharma Inc. (BNTC) is dated October 14, 2025. Benitec Biopharma Inc. reported in an 8-K filed May 29, 2026 that Megan Boston resigned as member of the Board, effective May 22, 2026. Benitec Biopharma Inc. reported in an 8-K filed December 13, 2024 that Megan Boston was appointed Chief Financial Officer, effective January 1, 2025. The proxy statement of Benitec Biopharma Inc. reports total compensation of $8,599,293 for Megan Boston in fiscal 2025, including a base salary of $445,610. Disclosed compensation is on record for 4 fiscal years. Benitec Biopharma Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Benitec Biopharma Inc. includes Dr. Jerel Banks (CEO and Chairman), Sophie Mukadam (COO), David Friedman (Board Member) and 7 others.
“On May 22, 2026, Megan Boston, the Company's chief financial officer and secretary and a member of the Board since 2016, notified the Board of her decision to resign solely from the Board and rotated off the Board as part of the Company's ongoing Board composition and governance review.”
“effective as of January 1, 2025, as Chief Financial Officer of the Company.”
Affiliation history
-
Current
Start not stated–present
Last confirmed October 14, 2025
-
Start not stated–2026-05-22
Company network
Leadership on record at Benitec Biopharma Inc.
- Dr. Jerel Banks CEO, Chairman
- Sophie Mukadam COO
- David Friedman Board Member
- Dr. Sharon Mates Board Member
- Edward Smith Board Member
- J. Kevin Buchi Board Member
- Kishan "Kishen" Mehta Board Member
- Kishan ("Kishen") Mehta Board Member
- Kishen Mehta Board Member
- Peter Francis Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Benitec Biopharma Inc. (BNTC) | Chief Financial Officer, Secretary | $445,610 | $8,599,293 |
| 2024 | Benitec Biopharma Inc. (BNTC) | Chief Financial Officer, Secretary | $344,541 | $1,438,577 |
| 2023 | Benitec Biopharma Inc. (BNTC) | Executive Director | $303,733 | $469,457 |
| 2022 | Benitec Biopharma Inc. (BNTC) | Executive Director | $309,382 | $456,476 |